A framework and road map for rapid start-up and completion of a COVID-19 vaccine trial: A single clinical trial site experience

The COVID-19 global pandemic required the rapid development of vaccines with a quick start up of phase 1–3 studies with large enrollment targets. The University of California San Diego was identified as a site for the phase 3 trial of the mRNA-1273-SARS-CoV-2 vaccine. There were many challenges with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Carlos, Spector, Stephen A., Cale, Bernadette, Loughran, Megan, Lazaro, Leander, Mah, Eric, Firestein, Gary S., Gold, Kathryn A., Wallace, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Translational Science Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889226/
https://www.ncbi.nlm.nih.gov/pubmed/35291217
http://dx.doi.org/10.1017/cts.2022.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889226/
https://www.ncbi.nlm.nih.gov/pubmed/35291217
http://dx.doi.org/10.1017/cts.2022.3

Ejemplares similares